common.study.topics.clinical

Treatment of Moderate to Severe Glabellar Lines

common.study.values.description

Treatment of Moderate to Severe Glabellar Lines

The objective of the study is to evaluate the efficacy and safety of a single dose of QM1114-DP compared to placebo for the treatment of moderate to severe GL.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Biological - botulinum toxin

neuromodulator to be injected in the GL region

Biological - Placebo

Placebo to be injected in the GL area

participant.views.study.view.additional

participant.views.study.view.scientific-title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines

common.study.values.clinical-trial-id

NCT04249583

participant.views.study.view.id

aQWYqd